Announcements

Aims & Scope


Cannabis and Cannabinoid Research is the premier open access journal dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the biochemical mechanisms of endocannabinoids. The Journal publishes a broad range of human and animal studies including basic and translational research; clinical studies; behavioral, social, and epidemiological issues; and ethical, legal, and regulatory controversies.

Cannabis and Cannabinoid Research is the premier open source for authoritative cannabis and cannabinoid research, discussion, and debate. The Journal publishes under the Creative Commons Attribution 4.0 (CC BY) license to ensure broad dissemination and participation. All articles in Cannabis and Cannabinoid Research are rapidly reviewed and published online within 4 weeks of acceptance.

Cannabis and Cannabinoid Research coverage includes:

  • Biochemical process of the endocannabinoid system
  • Cannabinoid receptors and signaling
  • Pharmaceuticals based on cannabis and cannabinoids
  • Optimal dosing and drug delivery
  • Short- and long-term effects on the brain and behavior
  • Toxicological studies
  • Analgesic effects, including neuropathic pain and chronic nerve injury
  • Neurological disorders, including epilepsy, multiple sclerosis, and glaucoma
  • Use of cannabis as antinauseants and antispasmodics
  • Immune function and chronic inflammation, including HIV
  • Cancer and cancer-related treatment
  • Screening and assessment for marijuana misuse and addiction
  • Social, behavioral, and public health impact
  • Ethics, regulation, legalization, and public policy

Cannabis and Cannabinoid Research is under the editorial leadership of Daniele Piomelli, PhD, PharmD, the Louise Turner Arnold Chair in Neurosciences and Professor of Anatomy and Neurobiology, Pharmacology, and Biological Chemistry at University of California, Irvine.

Audience: Pharmacologists and psychopharmacologists, toxicologists, biochemists, neurologists, psychiatrists, physicians, and other healthcare practitioners, addiction specialists, and regulators and policymakers, among others

 

Benefits of publishing in Cannabis and Cannabinoid Research:

  • High visibility, immediate and unrestricted online access to published articles
  • Rigorous and rapid peer review
  • Easy compliance with open access mandates
  • Authors retain copyright
  • Highly indexed – citation tracking and inclusion in bibliographic databases
  • Targeted email marketing

 

Society Affiliation


In Collaboration with International Cannabinoid Research Society and International Association for Cannabinoid Medicines

Indexed/Abstracted in:

PubMed Central;

EMBASE/Excerpta Medica;

Scopus;

ProQuest databases;

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.